Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
Conditions
Keywords
recurrent breast cancer, psychosocial effects of cancer and its treatment
Brief summary
RATIONALE: Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of telephone counseling by breast cancer survivors on the well-being of women who have recurrent breast cancer.
Detailed description
OBJECTIVES: * Determine whether telephone counseling delivered by breast cancer survivors enhances the well-being of women with recurrent breast cancer. * Determine the impact of sociodemographic, clinical, and psychosocial predictors of well-being in these patients. * Determine the changes in well-being over time since disease recurrence in these patients. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to age (under 50 vs 50 and over), time since initial diagnosis (less than 2 years vs 2 years or more), and recurrence site (soft tissue without bone vs soft tissue with bone vs visceral). Patients are randomized to one of two study arms. * Arm I (control arm): Patients receive the standard level of support by continuing to use existing resources. Patients receive written materials from the counseling group at 6 months. * Arm II (intervention arm): Patients receive weekly telephone counseling sessions by breast cancer survivors over 4 weeks for a total of 4-8 sessions. Patients receive written materials from the counseling group after the first session. In both arms, quality of life is assessed at baseline and at 3 and 6 months. PROJECTED ACCRUAL: A total of 300 patients (150 per study arm) will be accrued for this study within 30 months.
Interventions
Questionnaire and telephone intervention
Sponsors
Study design
Eligibility
Inclusion criteria
DISEASE CHARACTERISTICS: * Received prior definitive surgical treatment for stage I-IIIa breast cancer with or without adjuvant chemotherapy, hormonal therapy, and/or radiotherapy * No more than 56 days since diagnosis of first recurrence * Any distant metastatic site, chest wall recurrence, scar recurrence, or nodal recurrence * No ipsilateral breast tumor recurrence after lumpectomy or isolated contralateral new primary breast tumors * Receiving or planning to receive first therapy for recurrence * No prior therapy for this recurrence except surgical treatment for in-breast relapse after lumpectomy or local palliative radiotherapy * Hormone receptor status: * Not specified PATIENT CHARACTERISTICS: Age: * Not specified Sex: * Female Menopausal status: * Not specified Performance status: * Not specified Life expectancy: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified Other: * No psychiatric diagnosis that would preclude study * Must be able to read and understand English PRIOR CONCURRENT THERAPY: Biologic therapy: * See Disease Characteristics Chemotherapy: * See Disease Characteristics Endocrine therapy: * See Disease Characteristics Radiotherapy: * See Disease Characteristics Surgery: * See Disease Characteristics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess effectiveness of a telephone intervention delivered by breast cancer survivors on well-being of patients experiencing a first recurrence of breast cancer | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Examine impact of sociodemographic, clinical, and psychosocial predictors of well-being in patients experiencing a first recurrence of breast cancer. | 6 months |
| Examine changes in well-being over time since recurrence | 6 months |
Countries
Canada, United States